Natural History of the Human Biological Response to Environmental Exposure and Injury
National Institute of Environmental Health Sciences (NIEHS) · NCT04888923
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–90 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2000
- US sites recruiting
- 1
- Study start
- November 16, 2021
- Record last updated
- October 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Background
Environmental exposures like pollution, diet, and stress can help cause human diseases, or make them worse. Researchers want to better understand how injury and inflammation are caused by these exposures. They want to collect biological and environmental samples and other data. They may use the samples to measure a range of factors, like hormones, toxins, and chemicals. This will help them improve their studies.
Objective
To identify and understand how environmental exposures contribute to human disease.
Eligibility
Healthy adults ages 18 and older
Design
Participants will be screened with questions about their health history, demographics, and medicines they take.
Participants may give blood, hair, stool, saliva, and/or urine samples. They may have a skin punch biopsy to collect skin cells. They may give fingernail or toenail clippings. They may give a sample of exhaled breath.
Participants may give a sputum sample. They will inhale a saline mist and cough mucus into a cup.
Participants may have their nasal passages brushed, scraped, or washed.
Participants may give cheek cell samples. They will swish mouthwash and spit it into a cup.
Participants who produce sperm may give samples.
Participants may have bronchoscopy to collect fluid. A saline solution will be put into their lung and then suctioned out, washing areas of the lung.
Participants may have a pelvic or transvaginal ultrasound. They may have lung function tests.
Participants may collect household dust, urine, or stool at home.
Participants will complete surveys about their health, diet, and exposures.
Participation will last for one or more study visits.
Participants may be contacted in the future to take part in other studies.
...
Conditions: Inflammation; Normal Controls; Metabolic Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
- INCLUSION CRITERIA:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Ability to provide informed consent.
- Able to read and speak English
- Male or female, aged >=18
- Able to travel to the NIEHS CRU for study visits or travel to an offsite event or conference.
EXCLUSION CRITERIA
An individual who meets any of the following criteria will be excluded from participation in this study:
- Not willing to have samples stored for future use.
- Current pregnancy or lactation, by participant verbal confirmation.
- Any condition that, in the investigator's opinion, places the participant at undue risk for complications associated with required study procedures.
Participants will be enrolled according to pre-defined host (e.g. disease, genetic, or demographic) or environmental (exposure) characteristics.
Recruiting US locations
NIEHS Clinical Research Unit (CRU)
Research Triangle Park, NC 27709
Site contact: NIEHS Join A Study Recruitment Group · 855-696-4347 · myniehs@nih.gov
Study contacts (from the official record)
- NIEHS Join A Study Recruitment Group · (855) 696-4347 · myniehs@nih.gov
- Lawrence S Kirschner, M.D. · (984) 287-3562 · lawrence.kirschner@nih.gov
Similar studies in North Carolina
All nutrition & metabolism studies in North Carolina →- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Charlotte, NC + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Asheville, NC + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Boehringer Ingelheim
- Location
- Fayetteville, NC + 123 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
Opus Genetics, Inc
- Location
- Garner, NC + 19 other US sites
- Eligibility basics
- Ages 18+